Karolinska Development (investor - Corporate Investor)

See something wrong or missing? Let us know
Offices:
Stockholm
Average round investment:
5.03M USD

Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatest return on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.

Showing 3 of 8 tracked Nordic investments in:

NameDateRound valueTotal raised
Sweden AtheraApr 20172.02M4.84M
Sweden Modus TherapeuticsFeb 20173.59M3.59M
Sweden PromimicSep 20162.8M2.8M

* The round values and totals raised are in USD.
** Click on the company for its details and on the round amount for the investment details.

Karolinska Development investments breakdown analysis:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

Investors with similar profile to Karolinska Development:

You need an account to access this feature. Login or create one from here. (it takes 20 seconds)

News about Karolinska Development